Form 4: Femasys Director Acquires Warrants in Private Placement

Femasys Inc. Director Charles Larsen acquired 34,122 Series D-1 Warrants with an exercise price of $0.58 per share.

Summary

• Director Charles Larsen of Femasys Inc. acquired 34,122 Series D-1 Warrants.
• The warrants have an initial exercise price of $0.58 per share of Common Stock.
• The warrants are exercisable from March 19, 2026, and expire on March 19, 2036.
• The acquisition was part of a private placement, issued as consideration in connection with an Omnibus Amendment and Consent Agreement dated March 19, 2026.
• The exercise of these warrants is subject to certain limitations in accordance with rules of the Nasdaq Capital Market.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as a director's acquisition of warrants suggests confidence in the company's future value, despite potential future dilution.

Positives

• A director increasing their potential stake in the company through warrant acquisition can signal confidence in future performance.
• The warrants were issued as consideration in an agreement, suggesting a resolution or advancement of a corporate matter.

Negatives

• The issuance of warrants could lead to dilution of existing shareholders if exercised, though the impact of 34,122 shares would need to be assessed in context of total outstanding shares.

Risks

• Potential future dilution of existing shareholders if the warrants are exercised.
• The exercise price of $0.58 per share may be below the current market price, making exercise more likely and increasing dilution risk.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance beyond the terms of the warrants themselves.

Industry Context

StockSavvy.ai notes that insider warrant acquisitions, especially by directors, are often viewed by the market as a positive signal, indicating management's belief in the company's long-term prospects. This transaction is a routine disclosure for insider equity changes.

Related Party Transactions

• The issuance of Series D-1 Warrants to Charles Larsen, a director of Femasys Inc., as consideration in an agreement, constitutes a related party transaction.

Stakeholder Impact

• Shareholders: Potential for future dilution if warrants are exercised, but also a signal of insider confidence.
• Company: Potential for capital inflow if warrants are exercised.

Next Steps

• The reporting person may choose to exercise the Series D-1 Warrants at or after March 19, 2026, and before March 19, 2036.

Key Dates

Recommendation

While a director's acquisition of warrants can be a positive signal of confidence, this Form 4 primarily reports a transaction rather than new operational or financial performance data. The potential for future dilution from warrant exercise warrants a 'hold' rather than a 'buy' without further context on the company's overall financial health and strategic direction.

Keywords

Femasys Inc., FEMY, Form 4, Insider Trading, Warrants, Director, Beneficial Ownership, Private Placement, Equity, Dilution